MilWealth Group’s Avanos Medical AVNS Stock Holding History

MilWealth Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37	Closed	-$1.1K	–	58
2023 Q1	$1.1K	Buy	+37	New	+$1.07K	﹤0.01%	60

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MilWealth Group's AVNS Position: Q2 2023 in Review

MilWealth Group sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 37 shares — an estimated $1.1K sold.

MilWealth Group first reported a position in AVNS in Q1 2023 and held it in 1 quarter. The position peaked at $1.1K in Q1 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

MilWealth Group reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
MilWealth Group sold 37 Avanos Medical shares in Q2 2023, an estimated $1.1K.
MilWealth Group first reported a position in Avanos Medical in Q1 2023 and held it in 1 quarter.
MilWealth Group's Avanos Medical position peaked at $1.1K in Q1 2023.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on MilWealth Group's 13F filing for Q2 2023, filed 24 Jul 2023.